Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.

PMID:
28844193
2.

Multinodular vacuolating and neuronal tumor of the cerebrum.

Badat N, Savatovsky J, Charbonneau F, Collin A, Lecler A.

Neurology. 2017 Jul 18;89(3):304-305. doi: 10.1212/WNL.0000000000004123. No abstract available.

PMID:
28716873
3.

Repeatability of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0 Tesla in orbital lesions.

Lecler A, Savatovsky J, Balvay D, Zmuda M, Sadik JC, Galatoire O, Charbonneau F, Bergès O, Picard H, Fournier L.

Eur Radiol. 2017 Jul 4. doi: 10.1007/s00330-017-4933-6. [Epub ahead of print]

PMID:
28677061
4.

Incidence and Prognostic Implications of Late Bleeding After Myocardial Infarction or Unstable Angina According to Treatment Strategy.

Brinkert M, Southern DA, James MT, Knudtson ML, Anderson TJ, Charbonneau F.

Can J Cardiol. 2017 Aug;33(8):998-1005. doi: 10.1016/j.cjca.2017.05.001. Epub 2017 May 5.

PMID:
28669702
5.

TIPIC Syndrome: Beyond the Myth of Carotidynia, a New Distinct Unclassified Entity.

Lecler A, Obadia M, Savatovsky J, Picard H, Charbonneau F, Menjot de Champfleur N, Naggara O, Carsin B, Amor-Sahli M, Cottier JP, Bensoussan J, Auffray-Calvier E, Varoquaux A, De Gaalon S, Calazel C, Nasr N, Volle G, Jianu DC, Gout O, Bonneville F, Sadik JC.

AJNR Am J Neuroradiol. 2017 Jul;38(7):1391-1398. doi: 10.3174/ajnr.A5214. Epub 2017 May 11.

PMID:
28495942
6.

[Intractable vomiting].

Chehaibou I, Charbonneau F, Deschamps R.

Rev Med Interne. 2015 Jun;36(6):432-4. doi: 10.1016/j.revmed.2014.11.001. Epub 2014 Nov 13. French. No abstract available.

PMID:
25475827
7.

Methods for sample acquisition and processing of serial blood and tumor biopsies for multicenter diffuse large B-cell lymphoma clinical trials.

Nielsen TH, Diaz Z, Christodoulopoulos R, Charbonneau F, Qureshi S, Rousseau C, Benlimame N, Camlioglu E, Constantin AM, Oros KK, Krumsiek J, Crump M, Morin RD, Cerchietti L, Johnson NA, Petrogiannis-Haliotis T, Miller WH Jr, Assouline SE, Mann KK.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2688-93. doi: 10.1158/1055-9965.EPI-14-0549.

8.

Tumor pathology of the orbit.

Héran F, Bergès O, Blustajn J, Boucenna M, Charbonneau F, Koskas P, Lafitte F, Nau E, Roux P, Sadik JC, Savatovsky J, Williams M.

Diagn Interv Imaging. 2014 Oct;95(10):933-44. doi: 10.1016/j.diii.2014.08.002. Epub 2014 Sep 5. Review.

9.

Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Power LA, Sessink PJ, Gesy K, Charbonneau F.

Hosp Pharm. 2014 Apr;49(4):355-62. doi: 10.1310/hpj4904-355.

10.

No more fear of the cavernous sinuses!

Charbonneau F, Williams M, Lafitte F, Héran F.

Diagn Interv Imaging. 2013 Oct;94(10):1003-16. doi: 10.1016/j.diii.2013.08.012. Epub 2013 Oct 5.

11.

The relationship between anthropometric indexes of adiposity and vascular function in the FATE cohort.

Martin BJ, Verma S, Charbonneau F, Title LM, Lonn EM, Anderson TJ.

Obesity (Silver Spring). 2013 Feb;21(2):266-73. doi: 10.1002/oby.20266.

12.

Hyperfrontality and hypoconnectivity during refreshing in schizophrenia.

Grillon ML, Oppenheim C, Varoquaux G, Charbonneau F, Devauchelle AD, Krebs MO, Baylé F, Thirion B, Huron C.

Psychiatry Res. 2013 Mar 30;211(3):226-33. doi: 10.1016/j.pscychresns.2012.09.001. Epub 2012 Nov 5.

13.

CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation.

Tourigny A, Charbonneau F, Xing P, Boukrab R, Rousseau G, St-Arnaud R, Brezniceanu ML.

PLoS One. 2012;7(10):e48652. doi: 10.1371/journal.pone.0048652. Epub 2012 Oct 31.

14.

Diffusion MR imaging of the optic nerve in a patient with giant-cell arteritis and vertebral artery vasculitis.

Biotti D, Savatovski J, Bidot S, Shotar E, Charbonneau F, Obadia M, Gueguen A.

Eur Neurol. 2011;66(2):83-4. doi: 10.1159/000329885. Epub 2011 Jul 21. No abstract available.

PMID:
21778731
15.

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR; RIVAL trial group.

Lancet. 2011 Apr 23;377(9775):1409-20. doi: 10.1016/S0140-6736(11)60404-2. Epub 2011 Apr 4. Erratum in: Lancet. 2011 Apr 23;377(9775):1408. Lancet. 2011 Jul 2;378(9785):30.

PMID:
21470671
16.

Dose-dependent antihypertensive efficacy and tolerability of perindopril in a large, observational, 12-week, general practice-based study.

Tsoukas G, Anand S, Yang K; CONFIDENCE Investigators.

Am J Cardiovasc Drugs. 2011;11(1):45-55. doi: 10.2165/11587000-000000000-00000.

PMID:
21265582
17.

Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study.

Anderson TJ, Charbonneau F, Title LM, Buithieu J, Rose MS, Conradson H, Hildebrand K, Fung M, Verma S, Lonn EM.

Circulation. 2011 Jan 18;123(2):163-9. doi: 10.1161/CIRCULATIONAHA.110.953653. Epub 2011 Jan 3.

18.

Key components of intravenous chemotherapy labeling: a systematic review and practice guideline.

Trudeau M, Green E, Cosby R, Charbonneau F, Easty T, Ko Y, Marchand P, David U, Berger N, Hertz S.

J Oncol Pharm Pract. 2011 Dec;17(4):409-24. doi: 10.1177/1078155210385160. Epub 2010 Sep 27. Review.

PMID:
20876081
19.

Creating synergy in our health system: The challenges of primary angioplasty.

Charbonneau F.

Can J Cardiol. 2009 Nov;25(11):e387-8. No abstract available.

20.

Cerebral vasculopathy is associated with severe vascular manifestations in systemic sclerosis.

Terrier B, Charbonneau F, Touzé E, Berezne A, Pagnoux C, Silvera S, Meder JF, Guillevin L, Oppenheim C, Mouthon L.

J Rheumatol. 2009 Jul;36(7):1486-94. doi: 10.3899/jrheum.081222. Epub 2009 Jun 16.

PMID:
19531752

Supplemental Content

Loading ...
Support Center